Informing public policy

There is an ongoing need to ensure that advances in genomics, biomedical science and associated technology are implemented in a responsible way, with due consideration of their ethical, legal and social implications (often shortened to the acronym ELSI).

Our previous experience in the policy field ranges from theoretical analysis of the concepts underlying issues such as genetic information and informed consent, to applied policy work involving detailed scrutiny of the current legislative and regulatory framework and proposed new legislation. Our goal has always been to make a practical contribution to the policy debate, ensuring that our analysis and recommendations are informed by an understanding of the views and experience of scientists and clinicians.

Selected major projects have included:

• Human tissue
• The use and protection of medical information
• Regulatory issues in stem cell research and therapy
• Policy issues in the evaluation of clinical genetic testing for complex disorders

Responses to consultations have included:

• Genetics White Paper: three year review (2006)
• On the Draft Code of Practice to the Mental Capacity Act 2005 (2006)
• On Lasting Powers of Attorney (LPA) - forms and guidance (DCA CP 01/06)
• On implementing the recommendations of the Report of the Ad Hoc Advisory Group on the Operation of NHS Research Ethics (2006)
• 'Human Reproductive Technologies and the Law' (2005)
• Choices and Boundaries (2005)
• Pharmacogenetics (2004)